News
Dean
Introduction
Organization
Faculty
Research Highlights
Students
Admission
Research Day
Location
Activity Features
National Taiwan University    |     NTU, College of Medicine
NTU, Department of Pharmacy
Graduate Institute of Clinical Pharmacy
Drug Research Center    |     Ching Kang Foundation
Center for Innovative Therapeutics Discovery
NTUH,Department of Pharmacy
Taiwan Society of Health-System Pharmacists
Alumni    |     Alumni in North America    |     AASP    |    
Instrumentation Booking System    |     Platform for Research and Inspiration in Regulatory Science
© copyright 2014 SP, NTU. All Rights Reserved.
No.33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100025, Taiwan (R.O.C.)
TEL : (02)3366-8750~4    FAX : (02)2391-9098
Web person in charge: Tang-Yih Hsu
Contact Phone : (02)33668743
Latest Update : 2024 / 10 / 24
Privacy & Security Policy
Faculty
back
Chia-Ron Yang
Title：Professor / Director, Drug Research Center
TEL：+886-2-3366-8758     Email：cryang@ntu.edu.tw
NTU SCHOLAR
PortfolioPortfolio ResearchResearch
Published:
Research Projects:Subject：介白素-1貝他型在人類骨關節炎纖維母細胞樣滑膜細胞調控顆粒球群落刺激因子及缺氧調控因子-2阿爾發型表現之機轉探討：以阻斷介白素-1貝它型引起的訊息傳遞為考量的發炎性關節炎之新型藥物研發
Duration：2011-08 ~ 2014-07
Principal Investigator：Chia-Ron Yang
Subject：新型選擇性HDAC6抑制劑在人類癌症治療之藥理研究
Duration：2014-01 ~ 2016-12
Principal Investigator：Chia-Ron Yang
Subject：Denbinobin系列衍生物之抗關節炎活性評估與機轉探討
Duration：2014-08 ~ 2017-07
Principal Investigator：Chia-Ron Yang
Subject：Development of selective histone deacetylase 6 inhibitors for the treatment of Alzheimer’s disease
Duration：2016-05 ~ 2017-04
Principal Investigator：Chia-Ron Yang
Subject：Development of aroylindolylcinnamide selective histone deacetylase inhibitors as anti-cancer agents
Duration：2017-08 ~ 2020-07
Principal Investigator：Chia-Ron Yang
Subject：Characterization of the mechanisms of histone deacetylase 6 in glioblastoma multiforme growth and the specific histone deacetylase 6 inhibitor lead compound development
Duration：2020-08 ~ 2023-07
Principal Investigator：Chia-Ron Yang
Subject：Novel cyclin-dependent kinase 8 inhibitor lead compound development and application in pulmonary fibrosis
Duration：2022-08 ~ 2025-07
Principal Investigator：Chia-Ron Yang